| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 3.32e-07 | 98 | 30 | 5 | GO:0048306 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.12e-05 | 303 | 30 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.04e-04 | 61 | 30 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.99e-04 | 739 | 30 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.38e-03 | 562 | 30 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.61e-03 | 582 | 30 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 3.66e-03 | 60 | 30 | 2 | GO:0005544 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.79e-03 | 749 | 30 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.90e-03 | 753 | 30 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 5.37e-03 | 73 | 30 | 2 | GO:0001786 | |
| GeneOntologyBiologicalProcess | multivesicular body sorting pathway | 4.97e-05 | 51 | 29 | 3 | GO:0071985 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 8.14e-05 | 1390 | 29 | 9 | GO:0045944 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.22e-04 | 1377 | 31 | 9 | GO:0140513 | |
| GeneOntologyCellularComponent | npBAF complex | 1.92e-04 | 14 | 31 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 2.52e-04 | 16 | 31 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 9.02e-04 | 30 | 31 | 2 | GO:0016514 | |
| Domain | ALIX_V_dom | 2.67e-06 | 2 | 31 | 2 | IPR025304 | |
| Domain | ALIX_LYPXL_bnd | 2.67e-06 | 2 | 31 | 2 | PF13949 | |
| Domain | DVL-1 | 2.67e-06 | 2 | 31 | 2 | IPR008340 | |
| Domain | DUF1897 | 2.67e-06 | 2 | 31 | 2 | PF09005 | |
| Domain | DUF1897 | 2.67e-06 | 2 | 31 | 2 | IPR015096 | |
| Domain | Dishevelled | 1.60e-05 | 4 | 31 | 2 | PF02377 | |
| Domain | Dishevelled_protein_dom | 1.60e-05 | 4 | 31 | 2 | IPR003351 | |
| Domain | Dishevelled_fam | 1.60e-05 | 4 | 31 | 2 | IPR008339 | |
| Domain | - | 2.66e-05 | 5 | 31 | 2 | 1.25.40.280 | |
| Domain | BRO1 | 2.66e-05 | 5 | 31 | 2 | PF03097 | |
| Domain | BRO1_dom | 2.66e-05 | 5 | 31 | 2 | IPR004328 | |
| Domain | BRO1 | 2.66e-05 | 5 | 31 | 2 | SM01041 | |
| Domain | BRO1 | 2.66e-05 | 5 | 31 | 2 | PS51180 | |
| Domain | - | 3.63e-05 | 39 | 31 | 3 | 3.30.1370.10 | |
| Domain | KH_dom_type_1 | 5.24e-05 | 44 | 31 | 3 | IPR004088 | |
| Domain | DIX | 5.57e-05 | 7 | 31 | 2 | IPR001158 | |
| Domain | DIX | 5.57e-05 | 7 | 31 | 2 | PS50841 | |
| Domain | DAX | 5.57e-05 | 7 | 31 | 2 | SM00021 | |
| Domain | DIX | 5.57e-05 | 7 | 31 | 2 | PF00778 | |
| Domain | Annexin | 2.06e-04 | 13 | 31 | 2 | PF00191 | |
| Domain | ANX | 2.06e-04 | 13 | 31 | 2 | SM00335 | |
| Domain | ANNEXIN | 2.06e-04 | 13 | 31 | 2 | PS00223 | |
| Domain | Annexin_repeat | 2.06e-04 | 13 | 31 | 2 | IPR018502 | |
| Domain | - | 2.06e-04 | 13 | 31 | 2 | 1.10.220.10 | |
| Domain | Annexin_repeat_CS | 2.06e-04 | 13 | 31 | 2 | IPR018252 | |
| Domain | Annexin | 2.40e-04 | 14 | 31 | 2 | IPR001464 | |
| Domain | DEP | 6.03e-04 | 22 | 31 | 2 | PF00610 | |
| Domain | DEP | 6.03e-04 | 22 | 31 | 2 | SM00049 | |
| Domain | DEP | 6.03e-04 | 22 | 31 | 2 | PS50186 | |
| Domain | DEP_dom | 6.60e-04 | 23 | 31 | 2 | IPR000591 | |
| Domain | KH_1 | 1.81e-03 | 38 | 31 | 2 | PF00013 | |
| Domain | KH | 2.00e-03 | 40 | 31 | 2 | SM00322 | |
| Domain | KH_dom | 2.00e-03 | 40 | 31 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 2.20e-03 | 42 | 31 | 2 | PS50084 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 7.56e-05 | 149 | 22 | 4 | M4076 | |
| Pubmed | 3.11e-09 | 615 | 32 | 9 | 31048545 | ||
| Pubmed | 3.55e-09 | 261 | 32 | 7 | 33277362 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 4.26e-09 | 147 | 32 | 6 | 28977470 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.67e-09 | 457 | 32 | 8 | 32344865 | |
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 12445460 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CYSTM1 VPS37C PTPN23 PEF1 PDCD6IP PRRC2A PLSCR1 ANXA7 ANXA11 CRTC2 | 1.56e-08 | 1016 | 32 | 10 | 19056867 |
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 20691033 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.24e-08 | 807 | 32 | 9 | 22681889 | |
| Pubmed | NCOA1 PRPF6 ARID1B FAM120A RUNX1 DAZAP1 KHDC4 PRRC2A FUBP1 KHSRP | 3.38e-08 | 1103 | 32 | 10 | 34189442 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.73e-08 | 220 | 32 | 6 | 35785414 | |
| Pubmed | 8.34e-08 | 634 | 32 | 8 | 34591612 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.01e-07 | 922 | 32 | 9 | 27609421 | |
| Pubmed | 1.05e-07 | 653 | 32 | 8 | 22586326 | ||
| Pubmed | Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 1.32e-07 | 50 | 32 | 4 | 27716508 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.35e-07 | 954 | 32 | 9 | 36373674 | |
| Pubmed | 1.54e-07 | 453 | 32 | 7 | 29656893 | ||
| Pubmed | 2.73e-07 | 152 | 32 | 5 | 38360978 | ||
| Pubmed | 2.82e-07 | 153 | 32 | 5 | 28225217 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.91e-07 | 315 | 32 | 6 | 26777405 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19585652 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19003864 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 33005010 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34288405 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 20093729 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 8644734 | ||
| Pubmed | 1.08e-06 | 22 | 32 | 3 | 12456657 | ||
| Pubmed | 1.59e-06 | 217 | 32 | 5 | 30619736 | ||
| Pubmed | 1.70e-06 | 220 | 32 | 5 | 24550385 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.38e-06 | 989 | 32 | 8 | 36424410 | |
| Pubmed | Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII). | 2.46e-06 | 3 | 32 | 2 | 9268363 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 30500954 | ||
| Pubmed | ALG-2 interacts with the amino-terminal domain of annexin XI in a Ca(2+)-dependent manner. | 2.46e-06 | 3 | 32 | 2 | 11883939 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 29127290 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 8940189 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 18434552 | ||
| Pubmed | Structural Basis for Selective Interaction between the ESCRT Regulator HD-PTP and UBAP1. | 2.46e-06 | 3 | 32 | 2 | 27839950 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.08e-06 | 1024 | 32 | 8 | 24711643 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.60e-06 | 462 | 32 | 6 | 31138677 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.69e-06 | 258 | 32 | 5 | 37794589 | |
| Pubmed | 3.88e-06 | 1429 | 32 | 9 | 35140242 | ||
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 4.35e-06 | 119 | 32 | 4 | 35776542 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.63e-06 | 1082 | 32 | 8 | 38697112 | |
| Pubmed | Synovial sarcoma translocation (SYT) encodes a nuclear receptor coactivator. | 4.92e-06 | 4 | 32 | 2 | 15919756 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 8817329 | ||
| Pubmed | VPS37 isoforms differentially modulate the ternary complex formation of ALIX, ALG-2, and ESCRT-I. | 4.92e-06 | 4 | 32 | 2 | 23924735 | |
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 4.92e-06 | 4 | 32 | 2 | 9192851 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 37156809 | ||
| Pubmed | Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. | 4.92e-06 | 4 | 32 | 2 | 20639201 | |
| Pubmed | 5.07e-06 | 1477 | 32 | 9 | 31515488 | ||
| Pubmed | 5.10e-06 | 491 | 32 | 6 | 22623428 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 5.79e-06 | 283 | 32 | 5 | 28533407 | |
| Pubmed | 8.10e-06 | 1168 | 32 | 8 | 19946888 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 26866605 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 8938449 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 19403673 | ||
| Pubmed | 9.83e-06 | 551 | 32 | 6 | 34728620 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.20e-05 | 329 | 32 | 5 | 34316702 | |
| Pubmed | 1.30e-05 | 1247 | 32 | 8 | 27684187 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.43e-05 | 341 | 32 | 5 | 32971831 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.64e-05 | 351 | 32 | 5 | 38297188 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 23540691 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 9434938 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 11003644 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 15509564 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.78e-05 | 357 | 32 | 5 | 37059091 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.11e-05 | 370 | 32 | 5 | 22922362 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 19643732 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 22773187 | ||
| Pubmed | 2.34e-05 | 60 | 32 | 3 | 34761192 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.35e-05 | 1353 | 32 | 8 | 29467282 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 17174262 | ||
| Pubmed | UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. | 2.94e-05 | 9 | 32 | 2 | 21757351 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.99e-05 | 398 | 32 | 5 | 35016035 | |
| Pubmed | 3.02e-05 | 399 | 32 | 5 | 35987950 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 3.06e-05 | 400 | 32 | 5 | 35013556 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.23e-05 | 1415 | 32 | 8 | 28515276 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.40e-05 | 1425 | 32 | 8 | 30948266 | |
| Pubmed | 3.50e-05 | 202 | 32 | 4 | 29540532 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.90e-05 | 704 | 32 | 6 | 29955894 | |
| Pubmed | 3.99e-05 | 707 | 32 | 6 | 19738201 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 4.21e-05 | 714 | 32 | 6 | 28302793 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.64e-05 | 1489 | 32 | 8 | 28611215 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 11734557 | ||
| Pubmed | 5.70e-05 | 754 | 32 | 6 | 35906200 | ||
| Pubmed | Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. | 6.36e-05 | 13 | 32 | 2 | 17853893 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 7.41e-05 | 14 | 32 | 2 | 36289231 | |
| Pubmed | 7.55e-05 | 484 | 32 | 5 | 31995728 | ||
| Pubmed | 7.70e-05 | 486 | 32 | 5 | 20936779 | ||
| Pubmed | 8.23e-05 | 493 | 32 | 5 | 15368895 | ||
| Pubmed | 8.31e-05 | 494 | 32 | 5 | 26831064 | ||
| Pubmed | 8.41e-05 | 809 | 32 | 6 | 32129710 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 23785148 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 24189637 | ||
| Pubmed | 9.05e-05 | 503 | 32 | 5 | 16964243 | ||
| Pubmed | 9.84e-05 | 97 | 32 | 3 | 25071155 | ||
| Pubmed | 1.14e-04 | 274 | 32 | 4 | 34244482 | ||
| Pubmed | 1.36e-04 | 549 | 32 | 5 | 38280479 | ||
| Pubmed | 1.59e-04 | 114 | 32 | 3 | 31553912 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.79e-04 | 582 | 32 | 5 | 20467437 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 2.02e-04 | 1367 | 32 | 7 | 32687490 | |
| Interaction | WWP2 interactions | VPS37C PEF1 PRPF6 ARID1B FAM120A PDCD6IP SEC24C DAZAP1 TULP4 PRRC2A SUPT5H KHSRP DVL1 | 1.74e-10 | 840 | 32 | 13 | int:WWP2 |
| Interaction | PDCD6 interactions | 8.20e-10 | 204 | 32 | 8 | int:PDCD6 | |
| Interaction | NUP35 interactions | 1.36e-08 | 424 | 32 | 9 | int:NUP35 | |
| Interaction | WWOX interactions | VPS37C VOPP1 PEF1 PDCD6IP SEC24C DAZAP1 PRRC2A ANXA11 KHSRP DVL1 | 2.75e-08 | 627 | 32 | 10 | int:WWOX |
| Interaction | VPS37C interactions | 8.22e-08 | 141 | 32 | 6 | int:VPS37C | |
| Interaction | TLE3 interactions | 9.69e-08 | 376 | 32 | 8 | int:TLE3 | |
| Interaction | CEP55 interactions | 1.26e-07 | 256 | 32 | 7 | int:CEP55 | |
| Interaction | PIR interactions | 1.94e-07 | 83 | 32 | 5 | int:PIR | |
| Interaction | TIAL1 interactions | 2.67e-07 | 172 | 32 | 6 | int:TIAL1 | |
| Interaction | SNRNP40 interactions | 4.35e-07 | 637 | 32 | 9 | int:SNRNP40 | |
| Interaction | ALG2 interactions | 6.80e-07 | 44 | 32 | 4 | int:ALG2 | |
| Interaction | NEDD4 interactions | 1.59e-06 | 544 | 32 | 8 | int:NEDD4 | |
| Interaction | BRCA1 interactions | NCOA1 PRPF6 ZMIZ1 FAM120A RUNX1 PDCD6IP SEC24C DAZAP1 SUPT5H FUBP1 KHSRP | 1.91e-06 | 1249 | 32 | 11 | int:BRCA1 |
| Interaction | SMARCC1 interactions | 1.93e-06 | 384 | 32 | 7 | int:SMARCC1 | |
| Interaction | EYA4 interactions | 2.01e-06 | 243 | 32 | 6 | int:EYA4 | |
| Interaction | UBQLN2 interactions | 2.80e-06 | 797 | 32 | 9 | int:UBQLN2 | |
| Interaction | FAM168A interactions | 2.80e-06 | 142 | 32 | 5 | int:FAM168A | |
| Interaction | DAZL interactions | 3.10e-06 | 145 | 32 | 5 | int:DAZL | |
| Interaction | ETV4 interactions | 4.21e-06 | 69 | 32 | 4 | int:ETV4 | |
| Interaction | SP7 interactions | 7.30e-06 | 304 | 32 | 6 | int:SP7 | |
| Interaction | EWSR1 interactions | 7.94e-06 | 906 | 32 | 9 | int:EWSR1 | |
| Interaction | FUBP1 interactions | 8.02e-06 | 309 | 32 | 6 | int:FUBP1 | |
| Interaction | PRMT1 interactions | 9.72e-06 | 929 | 32 | 9 | int:PRMT1 | |
| Interaction | TNIP2 interactions | 1.18e-05 | 952 | 32 | 9 | int:TNIP2 | |
| Interaction | CEBPA interactions | NCOA1 PRPF6 ARID1B FAM120A RUNX1 DAZAP1 KHDC4 PRRC2A FUBP1 KHSRP | 1.44e-05 | 1245 | 32 | 10 | int:CEBPA |
| Interaction | SIRT7 interactions | 1.59e-05 | 744 | 32 | 8 | int:SIRT7 | |
| Interaction | AR interactions | 1.64e-05 | 992 | 32 | 9 | int:AR | |
| Interaction | SMC5 interactions | 1.75e-05 | 1000 | 32 | 9 | int:SMC5 | |
| Interaction | ANXA11 interactions | 1.84e-05 | 100 | 32 | 4 | int:ANXA11 | |
| Interaction | WDR77 interactions | 1.94e-05 | 361 | 32 | 6 | int:WDR77 | |
| Interaction | PEF1 interactions | 2.50e-05 | 108 | 32 | 4 | int:PEF1 | |
| Interaction | CTBP1 interactions | 3.75e-05 | 406 | 32 | 6 | int:CTBP1 | |
| Interaction | SOX2 interactions | ARID1B FAM120A PYGO2 RUNX1 DAZAP1 SS18 SUPT5H FUBP1 ANXA7 KHSRP | 4.54e-05 | 1422 | 32 | 10 | int:SOX2 |
| Interaction | WWTR1 interactions | 4.65e-05 | 422 | 32 | 6 | int:WWTR1 | |
| Interaction | CRX interactions | 4.66e-05 | 254 | 32 | 5 | int:CRX | |
| Interaction | BAG3 interactions | 4.90e-05 | 632 | 32 | 7 | int:BAG3 | |
| Interaction | TFG interactions | 5.02e-05 | 258 | 32 | 5 | int:TFG | |
| Interaction | FOXP3 interactions | 5.29e-05 | 432 | 32 | 6 | int:FOXP3 | |
| Interaction | ARID1A interactions | 6.91e-05 | 276 | 32 | 5 | int:ARID1A | |
| Interaction | CELF1 interactions | 8.45e-05 | 288 | 32 | 5 | int:CELF1 | |
| Interaction | PRR13 interactions | 9.52e-05 | 56 | 32 | 3 | int:PRR13 | |
| Interaction | FUBP3 interactions | 9.77e-05 | 297 | 32 | 5 | int:FUBP3 | |
| Interaction | FOS interactions | 1.23e-04 | 312 | 32 | 5 | int:FOS | |
| Interaction | FLI1 interactions | 1.29e-04 | 62 | 32 | 3 | int:FLI1 | |
| Interaction | IGF2BP1 interactions | 1.29e-04 | 508 | 32 | 6 | int:IGF2BP1 | |
| Interaction | CTNNB1 interactions | 1.38e-04 | 1009 | 32 | 8 | int:CTNNB1 | |
| Interaction | RUNX1 interactions | 1.47e-04 | 324 | 32 | 5 | int:RUNX1 | |
| Interaction | PRDX2 interactions | 1.58e-04 | 329 | 32 | 5 | int:PRDX2 | |
| Interaction | MEN1 interactions | 1.58e-04 | 1029 | 32 | 8 | int:MEN1 | |
| Interaction | DTX2 interactions | 1.60e-04 | 330 | 32 | 5 | int:DTX2 | |
| Interaction | BICRA interactions | 1.63e-04 | 67 | 32 | 3 | int:BICRA | |
| Interaction | TP53BP1 interactions | 1.68e-04 | 533 | 32 | 6 | int:TP53BP1 | |
| Interaction | RBM39 interactions | 1.72e-04 | 1042 | 32 | 8 | int:RBM39 | |
| Interaction | ITGA4 interactions | 1.93e-04 | 547 | 32 | 6 | int:ITGA4 | |
| Interaction | PRDX5 interactions | 1.98e-04 | 184 | 32 | 4 | int:PRDX5 | |
| Interaction | SMARCA2 interactions | 1.99e-04 | 346 | 32 | 5 | int:SMARCA2 | |
| Interaction | MYCN interactions | 2.06e-04 | 1373 | 32 | 9 | int:MYCN | |
| Interaction | DAZAP2 interactions | 2.06e-04 | 186 | 32 | 4 | int:DAZAP2 | |
| Interaction | ATN1 interactions | 2.11e-04 | 187 | 32 | 4 | int:ATN1 | |
| Interaction | SMARCC2 interactions | 2.19e-04 | 353 | 32 | 5 | int:SMARCC2 | |
| Interaction | CUL5 interactions | 2.35e-04 | 567 | 32 | 6 | int:CUL5 | |
| Interaction | EP300 interactions | 2.40e-04 | 1401 | 32 | 9 | int:EP300 | |
| Interaction | YAP1 interactions | 2.42e-04 | 1095 | 32 | 8 | int:YAP1 | |
| Interaction | MYOD1 interactions | 2.42e-04 | 194 | 32 | 4 | int:MYOD1 | |
| Interaction | SLX4 interactions | 2.46e-04 | 572 | 32 | 6 | int:SLX4 | |
| Interaction | SRI interactions | 2.55e-04 | 78 | 32 | 3 | int:SRI | |
| Interaction | DDA1 interactions | 2.65e-04 | 368 | 32 | 5 | int:DDA1 | |
| Interaction | G3BP1 interactions | 2.77e-04 | 835 | 32 | 7 | int:G3BP1 | |
| Interaction | RABGEF1 interactions | 2.94e-04 | 204 | 32 | 4 | int:RABGEF1 | |
| Interaction | CEBPB interactions | 2.99e-04 | 1443 | 32 | 9 | int:CEBPB | |
| Interaction | EED interactions | 3.02e-04 | 1445 | 32 | 9 | int:EED | |
| Interaction | CREBBP interactions | 3.15e-04 | 599 | 32 | 6 | int:CREBBP | |
| Interaction | IRF4 interactions | 3.29e-04 | 85 | 32 | 3 | int:IRF4 | |
| Interaction | HSF1 interactions | 3.44e-04 | 609 | 32 | 6 | int:HSF1 | |
| Interaction | TLE1 interactions | 3.46e-04 | 213 | 32 | 4 | int:TLE1 | |
| Interaction | STH interactions | 3.68e-04 | 18 | 32 | 2 | int:STH | |
| Interaction | PRMT2 interactions | 4.02e-04 | 91 | 32 | 3 | int:PRMT2 | |
| Interaction | GPI interactions | 4.05e-04 | 222 | 32 | 4 | int:GPI | |
| Interaction | FRAT1 interactions | 4.11e-04 | 19 | 32 | 2 | int:FRAT1 | |
| Interaction | TRAPPC13 interactions | 4.15e-04 | 92 | 32 | 3 | int:TRAPPC13 | |
| Interaction | ZNF326 interactions | 4.18e-04 | 224 | 32 | 4 | int:ZNF326 | |
| Interaction | BAG4 interactions | 4.18e-04 | 224 | 32 | 4 | int:BAG4 | |
| Interaction | HNRNPD interactions | 4.41e-04 | 638 | 32 | 6 | int:HNRNPD | |
| Interaction | PDCD6IP interactions | 4.86e-04 | 233 | 32 | 4 | int:PDCD6IP | |
| Interaction | RPRD1B interactions | 4.86e-04 | 233 | 32 | 4 | int:RPRD1B | |
| Interaction | AAR2 interactions | 5.15e-04 | 657 | 32 | 6 | int:AAR2 | |
| Interaction | SEC16A interactions | 5.18e-04 | 426 | 32 | 5 | int:SEC16A | |
| Interaction | BMI1 interactions | 5.24e-04 | 659 | 32 | 6 | int:BMI1 | |
| Interaction | INTS11 interactions | 5.45e-04 | 101 | 32 | 3 | int:INTS11 | |
| Interaction | PCBP1 interactions | 5.76e-04 | 671 | 32 | 6 | int:PCBP1 | |
| Interaction | TRPC4AP interactions | 5.77e-04 | 103 | 32 | 3 | int:TRPC4AP | |
| Interaction | KLHL12 interactions | 5.94e-04 | 104 | 32 | 3 | int:KLHL12 | |
| Interaction | ZFYVE16 interactions | 5.94e-04 | 104 | 32 | 3 | int:ZFYVE16 | |
| Interaction | SNRPC interactions | 6.00e-04 | 440 | 32 | 5 | int:SNRPC | |
| Interaction | TRAPPC12 interactions | 6.11e-04 | 105 | 32 | 3 | int:TRAPPC12 | |
| Interaction | PSMA3 interactions | 6.19e-04 | 443 | 32 | 5 | int:PSMA3 | |
| Interaction | SMAD3 interactions | 6.45e-04 | 447 | 32 | 5 | int:SMAD3 | |
| Interaction | RPA4 interactions | 6.78e-04 | 452 | 32 | 5 | int:RPA4 | |
| Interaction | TRIM33 interactions | 6.85e-04 | 453 | 32 | 5 | int:TRIM33 | |
| Interaction | ACTC1 interactions | 6.88e-04 | 694 | 32 | 6 | int:ACTC1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 1.33e-05 | 208 | 32 | 4 | chr10q22 | |
| Cytoband | 10q22.2 | 3.79e-04 | 41 | 32 | 2 | 10q22.2 | |
| Cytoband | 19p13.3 | 6.03e-04 | 237 | 32 | 3 | 19p13.3 | |
| Cytoband | 1q21.3 | 3.04e-03 | 117 | 32 | 2 | 1q21.3 | |
| GeneFamily | Annexins|Endogenous ligands | 4.32e-05 | 13 | 14 | 2 | 404 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN | 9.17e-06 | 243 | 31 | 5 | M41178 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | 1.91e-05 | 484 | 31 | 6 | M14665 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 2.37e-05 | 1399 | 31 | 9 | M535 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 5.36e-05 | 176 | 31 | 4 | M8952 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 6.38e-05 | 184 | 31 | 4 | M19988 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN | 8.47e-05 | 198 | 31 | 4 | M5670 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN | 8.64e-05 | 199 | 31 | 4 | M3738 | |
| Coexpression | GSE17721_CTRL_VS_CPG_12H_BMDC_DN | 8.64e-05 | 199 | 31 | 4 | M3770 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 8.64e-05 | 199 | 31 | 4 | M3191 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 8.64e-05 | 199 | 31 | 4 | M3197 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 8.64e-05 | 199 | 31 | 4 | M7374 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN | 8.81e-05 | 200 | 31 | 4 | M3779 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 8.81e-05 | 200 | 31 | 4 | M5991 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP | 8.81e-05 | 200 | 31 | 4 | M9833 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_DN | 8.81e-05 | 200 | 31 | 4 | M4806 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 1.39e-04 | 85 | 31 | 3 | M17423 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 1.69e-04 | 237 | 31 | 4 | M7068 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 197 | 32 | 4 | 179b56147cfb0a5f53c58615f2612b8ef68c8bb8 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-05 | 199 | 32 | 4 | 90b20fce27739f28609d664475a197eea586e030 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | b8dc5dc9fe3f52be11940d45959134b2a7575a8b | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-05 | 199 | 32 | 4 | bbf81fb20da8a28aac024207696c6ea00473a0df | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 617fd53c799722879acd8f2fd69b331d82e7bdb9 | |
| ToppCell | Control-Myeloid-TRAM2|Control / Disease group,lineage and cell class (2021.01.30) | 1.21e-05 | 199 | 32 | 4 | 5a08184573e524ce0e2974eed9817354890830a9 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 1.14e-05 | 5 | 32 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | cognitive function measurement, self reported educational attainment | 5.68e-04 | 355 | 32 | 4 | EFO_0004784, EFO_0008354 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 6.91e-04 | 160 | 32 | 3 | DOID:5844 (biomarker_via_orthology) | |
| Disease | sitting height ratio | 1.41e-03 | 51 | 32 | 2 | EFO_0007118 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 1.46e-03 | 52 | 32 | 2 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | nicotine dependence | 3.25e-03 | 78 | 32 | 2 | EFO_0003768 | |
| Disease | lung adenocarcinoma (is_marker_for) | 3.85e-03 | 85 | 32 | 2 | DOID:3910 (is_marker_for) | |
| Disease | cognitive function measurement | 3.98e-03 | 1434 | 32 | 6 | EFO_0008354 | |
| Disease | left ventricular structural measurement | 4.12e-03 | 88 | 32 | 2 | EFO_0008205 | |
| Disease | Malignant neoplasm of breast | 5.63e-03 | 1074 | 32 | 5 | C0006142 | |
| Disease | anxiety measurement | 6.13e-03 | 108 | 32 | 2 | EFO_0009863 | |
| Disease | Glioblastoma Multiforme | 6.46e-03 | 111 | 32 | 2 | C1621958 | |
| Disease | lipoprotein A measurement | 6.58e-03 | 112 | 32 | 2 | EFO_0006925 | |
| Disease | age at first birth measurement | 7.51e-03 | 120 | 32 | 2 | EFO_0009101 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGAYPGQPPVTYPGQ | 141 | P50995 | |
| PGQQQPVPSYPGYPG | 161 | P50995 | |
| PSPGGAPGQGPYPYS | 31 | Q5T035 | |
| QPQQSSPYPGGSYGP | 621 | Q8NFD5 | |
| SPYPGGSYGPPGPQR | 626 | Q8NFD5 | |
| PYGQQYPGQGPPSGQ | 1411 | Q8NFD5 | |
| PPYGGHQPGLYPQQP | 1426 | Q8NFD5 | |
| GYPGAPQPGGAPSYP | 71 | P20073 | |
| PPQGFPQGYGAPPQF | 276 | Q96EP5 | |
| SPYPYAPQPGVLGQP | 996 | Q9H3S7 | |
| PFQPSPYGQPGYPHG | 46 | Q7Z429 | |
| QGGYPQGPYPQGGYP | 66 | Q7Z429 | |
| QGPYPQGGYPQGPYP | 71 | Q7Z429 | |
| QGPYPQEGYPQGPYP | 81 | Q7Z429 | |
| QGPYPQGGYPQGPYP | 91 | Q7Z429 | |
| QGGYPQGPYPQSPFP | 96 | Q7Z429 | |
| MGPYNPAPYNPGPPG | 481 | Q96AE4 | |
| PPAPYAPQGWGNAYP | 501 | Q96AE4 | |
| PGQAPYPGPQQPSYP | 841 | Q8WUM4 | |
| QGPPGYSGYPGPQVS | 31 | O15162 | |
| VPSPGGAPGQGPYPY | 381 | Q9NZB2 | |
| NPGQQQPYFPSPAPG | 86 | Q9UBE8 | |
| PPGSYYPGPPNSGGQ | 21 | Q9UBV8 | |
| PGGPYGQPPPSSYGA | 86 | Q9UBV8 | |
| PLPSYPGANPQPAFG | 936 | A8CG34 | |
| GPGYPPPGNMNFPSQ | 151 | Q9BRQ0 | |
| MGGPYPPPQGYPYQG | 31 | Q9H1C7 | |
| YGTPYPPGPSGHGQQ | 531 | Q53ET0 | |
| PSNGYQSGYPVVPPP | 356 | Q7Z7F0 | |
| PWPLGQGYPYQYPGP | 531 | O14640 | |
| PWPLGQGYPYQYPGP | 506 | P54792 | |
| PPFGQPQPIYPGYHQ | 11 | P53992 | |
| SHYYQQPPGPVPGPA | 581 | Q92945 | |
| AAYYGQTPGPGGPQP | 686 | Q92945 | |
| PPYPGSSQAQGGPFQ | 356 | Q01196 | |
| NTPYPGGLNTPYPGG | 211 | O94906 | |
| QFPYPPNYGTNPGTP | 1166 | Q15788 | |
| GPQGPYRYPTPDGPS | 266 | P48634 | |
| YGGTPNPQTPGYPDP | 851 | O00267 | |
| GLPPYPHYQQAPGGP | 126 | Q8IZ63 | |
| YPGSYNNPPLPGVQA | 1191 | Q9NRJ4 | |
| NPGPGAQQPGPPYYT | 106 | Q96AW1 | |
| AQQPGPPYYTDPGGP | 111 | Q96AW1 | |
| PPQQQQYPGQQGYPG | 346 | Q15532 | |
| GPSQGGPGPQYPNYP | 366 | Q15532 | |
| GPGPQYPNYPQGQGQ | 371 | Q15532 | |
| QYGGYRPTQPGPPQP | 386 | Q15532 | |
| YPQQSPYPATGGKPP | 296 | A5D8V6 | |
| PYPGEPNYGNQQYGP | 406 | Q9ULJ6 |